These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1360630)

  • 1. Correction of ischaemic brain acidosis with SQ29,548/1-benzylimidazole.
    Pettigrew LC; Hazle JD; Gutierrez G; Smith CD; Ogletree ML
    Neurol Res; 1992 Sep; 14(4):335-9. PubMed ID: 1360630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane receptor antagonism and synthase inhibition in cerebral ischemia.
    Pettigrew LC; Kryscio RJ
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):211-7. PubMed ID: 8469680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
    O'Keefe EH; Liu EC; Greenberg R; Ogletree ML
    Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
    J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone treatment increases thromboxane function in rat cerebral arteries.
    Gonzales RJ; Ghaffari AA; Duckles SP; Krause DN
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H578-85. PubMed ID: 15764681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain.
    Pettigrew LC; Grotta JC; Rhoades HM; Wu KK
    Stroke; 1989 May; 20(5):627-32. PubMed ID: 2718203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition.
    Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.
    Huang RY; Li SS; Guo HZ; Huang Y; Zhang X; Li MY; Chen GG; Zeng X
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):375-86. PubMed ID: 24384873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of thromboxane in frusemide diuresis in rats.
    Melki TS; Foegh ML; Ramwell PW
    Clin Sci (Lond); 1986 Dec; 71(6):647-50. PubMed ID: 3791866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.
    Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
    Wilcox CS; Welch WJ; Snellen H
    Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective actions of a thromboxane receptor antagonist, SQ 29548 on the ischemic myocardium: morphologic and hemodynamic effects.
    Singh J; Seth SD; Manchanda SC; Seth S
    Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):105-10. PubMed ID: 9051718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of reperfusion injury in rat skeletal muscle following administration of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Cheng HT; Chang H
    Thorac Cardiovasc Surg; 1995 Apr; 43(2):73-6. PubMed ID: 7545331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.
    Zaugg CE; Hornstein PS; Zhu P; Simper D; Lüscher TF; Allegrini PR; Buser PT
    Circulation; 1996 Aug; 94(4):742-7. PubMed ID: 8772697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells.
    Hanasaki K; Nakano K; Kasai H; Arita H
    Biochem Pharmacol; 1989 Sep; 38(18):2967-76. PubMed ID: 2528958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.